|
Chronic Lymphocytic Leukemia Research Consortium
|
5P01CA081534-10
|
$3,970,539
|
$794,108
|
KIPPS, THOMAS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Emory-GA Tech Nanotechnology Center for Personalized an*
|
5U54CA119338-05
|
$3,691,806
|
$184,590
|
NIE, SHUMING
|
EMORY UNIVERSITY
|
|
Bone Marrow Transplantation in Human Disease
|
5P01CA015396-34
|
$3,012,562
|
$301,256
|
JONES, RICHARD
|
JOHNS HOPKINS UNIVERSITY
|
|
Hematopoietic Cell Transplantation for Hematologic Malignancies
|
5P01CA030206-27
|
$2,987,761
|
$597,552
|
FORMAN, STEPHEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Targeting Vessels in Tumors
|
7P01CA104898-05
|
$2,697,748
|
$269,775
|
TALAMINI, MARK
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
PRECLINICAL IN VITRO AND IN VIVO SCREENING ASSAYS FOR CANCER PREVENTIVE AGENT DEV
|
N01CN433002-006
|
$2,562,872
|
$256,287
|
LIPKIN, STEVEN
|
WEILL MED COLL OF CORNELL:1106246
|
|
THE THERAPY OF AML
|
5P01CA055164-17
|
$2,440,745
|
$122,037
|
ANDREEFF, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
SPORE in Prostate Cancer
|
5P50CA092629-09
|
$2,365,008
|
$1,182,504
|
SCARDINO, PETER
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Pediatric Oncology Branch Clinical Care and Education
|
ZIE BC 010764
|
$2,324,038
|
$116,202
|
Wayne, Alan
|
CCR (NCI)
|
|
DF/HCC Kidney Cancer SPORE
|
2P50CA101942-06A1
|
$2,300,000
|
$276,000
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
SPORE In Protate Cancer
|
5P50CA058236-15
|
$2,300,000
|
$460,000
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
SPORE in Cervical Cancer
|
2P50CA098252-06A1
|
$2,300,000
|
$299,000
|
WU, TZYY-CHOOU
|
JOHNS HOPKINS UNIVERSITY
|
|
SPORE in Prostate Cancer
|
2P50CA090386-06A2
|
$2,300,000
|
$161,000
|
LEE, CHUNG
|
NORTHWESTERN UNIVERSITY
|
|
University of Texas M.D. Anderson Cancer Center SPORE - Leukemia
|
5P50CA100632-07
|
$2,300,000
|
$184,000
|
ISSA, JEAN-PIERRE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
University of Texas SPORE in Lung Cancer
|
5P50CA070907-12
|
$2,300,000
|
$460,000
|
MINNA, JOHN
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
|
Pacific Ovarian Cancer Research Consortium
|
2P50CA083636-11
|
$2,290,683
|
$137,441
|
URBAN, NICOLE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
SPORE in Genitourinary Cancer
|
5P50CA091846-09
|
$2,233,299
|
$446,660
|
DINNEY, COLIN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
UTMDACC SPORE in Breast Cancer
|
5P50CA116199-05
|
$2,180,817
|
$545,204
|
HORTOBAGYI, GABRIEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
SPORE in Prostate Cancer
|
5P50CA091956-09
|
$2,179,681
|
$871,872
|
TINDALL, DONALD
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
Biology & Transplantation of the Human Stem Cell
|
5P01CA065493-15
|
$2,135,909
|
$1,601,932
|
MCGLAVE, PHILIP
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Epithelial Ovarian Cancer Program Project
|
5P01CA052477-17
|
$2,085,988
|
$208,599
|
SPRIGGS, DAVID
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
MOTILITY AND INVASION
|
5P01CA100324-07
|
$2,056,747
|
$205,675
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Genetic Approaches to Cancer Immunotherapy
|
5P01CA059350-16
|
$2,049,200
|
$1,127,060
|
SADELAIN, MICHEL
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
University of Texas MD Anderson SPORE in Ovarian Cancer
|
5P50CA083639-10
|
$2,001,032
|
$800,413
|
BAST, ROBERT
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Enhancing T Cell Therapy of Cancer
|
5P01CA094237-07
|
$1,961,712
|
$980,856
|
Heslop, Helen
|
BAYLOR COLLEGE OF MEDICINE
|
|
Washington University Molecular Imaging Center
|
5P50CA094056-09
|
$1,961,166
|
$353,010
|
PIWNICA-WORMS, David
|
WASHINGTON UNIVERSITY
|
|
Center for Molecular Imaging Research at MGH/HMS
|
5P50CA086355-10
|
$1,942,000
|
$485,500
|
WEISSLEDER, RALPH
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Tumor Hypoxia Imaging - Laboratory and Clinical Studies
|
5P01CA115675-04
|
$1,907,650
|
$247,995
|
LING, CLIFTON
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
MSKCC Center for Molecular Imaging in Cancer
|
5P50CA086438-09
|
$1,904,290
|
$190,429
|
LARSON, STEVEN
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
The UCLA Center for In Vivo Imaging in Cancer Biology
|
5P50CA086306-10
|
$1,884,833
|
$471,208
|
HERSCHMAN, HARVEY
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Clinical and Laboratory Studies of Malignant Lymphomas
|
5P01CA034233-25
|
$1,717,701
|
$343,540
|
LEVY, RONALD
|
STANFORD UNIVERSITY
|
|
CD8+ T cells and Immunological Tumor Regression
|
5P01CA097296-07
|
$1,493,912
|
$224,087
|
Schreiber, Hans
|
UNIVERSITY OF CHICAGO
|
|
Clinical and Immunologic Evaluation of ProstAtak for Prostate Cancer
|
4R44CA124032-02
|
$1,473,388
|
$1,473,388
|
Aguilar-Cordova, Estuardo
|
ADVANTAGENE, INC
|
|
Gene Therapy for Brain Tumors
|
5P01CA069246-13
|
$1,412,570
|
$593,279
|
HOCHBERG, FRED
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Translational Applications of mda-7/IL-24 in Cancer
|
5P01CA104177-05
|
$1,353,467
|
$676,734
|
FISHER, PAUL
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Adoptive Cell Transfer Immunotherapy of Cancer
|
ZIA BC 010984
|
$1,264,583
|
$505,833
|
Rosenberg, Steven
|
CCR (NCI)
|
|
Gene therapy of cancer
|
ZIA BC 010985
|
$1,264,583
|
$505,833
|
Rosenberg, Steven
|
CCR (NCI)
|
|
Prostate Cancer: Transition to Androgen-Independence
|
5P01CA077739-10
|
$1,263,386
|
$315,847
|
FRENCH, FRANK
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Immuno/Immunogene Therapies for Thoracic Malignancies
|
5P01CA066726-13
|
$1,203,367
|
$1,203,367
|
Albelda, STEVEN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Sphingolipids in Cancer Biology and Therapy
|
5P01CA097132-07
|
$1,144,225
|
$377,594
|
HANNUN, YUSUF
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Cell Production Facility Core
|
ZIC BC 011020
|
$1,143,255
|
$571,627
|
Dudley, Mark
|
CCR (NCI)
|
|
Cell Prep Core
|
ZIC BC 010905
|
$1,143,255
|
$571,627
|
Wunderlich, John
|
CCR (NCI)
|
|
Study of hereditary prostate cancer and human artificial chromosomes
|
ZIA BC 010413
|
$1,105,367
|
$442,147
|
Larionov, Vladimir
|
CCR (NCI)
|
|
City of Hope Lymphoma SPORE
|
3P50CA107399-05S1
|
$1,079,832
|
$269,958
|
forman, stephen
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
PRECLINICAL IN VITRO AND IN VIVO SCREENING ASSAYS FOR CANCER PREVENTIVE AGENT DEV
|
N01CN433003-006
|
$1,017,128
|
$101,713
|
MCCORMICK, DAVID
|
IIT RESCH INSTITUTE:1107221
|
|
Lambda Genetic Networks and Lambda Red-Mediated Recombination
|
ZIA BC 010336
|
$1,007,946
|
$251,986
|
Court, Donald
|
CCR (NCI)
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$956,040
|
$191,208
|
Gottesman, Michael
|
CCR (NCI)
|
|
Hematopoietic Stem Cell Gene Therapy for Leukocyte Adhesion Deficiency
|
ZIA SC 010384
|
$902,101
|
$451,050
|
Hickstein, Dennis
|
CCR (NCI)
|
|
Epigenetics, Stem Cells, and Cancer
|
5R01CA087869-09
|
$886,353
|
$265,906
|
JAENISCH, RUDOLF
|
WHITEHEAD INSTITUTE FOR BIOMEDICAL RES
|
|
Cytokine Gene Therapy of Cancer - Preclinical Studies
|
5P01CA100327-05
|
$858,309
|
$858,309
|
Storkus, Walter
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
Total relevant funding to Gene Therapy for this search: $68,363,970
|